CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 NRx Pharmaceuticals, Inc. - NRXP CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开仓* N/A
1 年变化* N/A
日范围* N/A
52 周范围 0.49-1.54
平均交易量(10 天) 696.74K
平均交易量(3 个月) 4.73M
市值 45.86M
市盈率 -100.00K
流通股 70.31M
收入 N/A
EPS -0.56
股息(收益率 %) N/A
贝塔 0.95
下一个财报发布日期 Aug 14, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low

NRx Pharmaceuticals, Inc. Events

时间(协调世界时) (UTC) 国家/地区 事件
Tuesday, July 18, 2023

时间(协调世界时) (UTC)

15:00

国家/地区

US

事件

NRX Pharmaceuticals Inc Annual Shareholders Meeting
NRX Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, August 14, 2023

时间(协调世界时) (UTC)

12:30

国家/地区

US

事件

Q2 2023 NRX Pharmaceuticals Inc Earnings Release
Q2 2023 NRX Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Monday, November 13, 2023

时间(协调世界时) (UTC)

13:30

国家/地区

US

事件

Q3 2023 NRX Pharmaceuticals Inc Earnings Release
Q3 2023 NRX Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0 0 0 0 0
总营业费用 44.335 115.675 0.55534 0.71319 1.0065
销售/一般/行政费用,总计 27.308 74.944 0.90741 0.71319 1.0065
营业收入 -44.335 -115.675 -0.55534 -0.71319 -1.0065
利息收入(费用),非经营净值 0.504 1.674 -0.51633 1.20582 1.08892
税前净收入 -39.754 -93.063 -1.07167 0.49263 0.08241
税后净收入 -39.754 -93.063 -1.08951 0.40843 0.0661
未计算非常项目前的净收益 -39.754 -93.063 -1.08951 0.40843 0.0661
净收入 -39.754 -93.063 -1.08951 0.40843 0.0661
普通股股东可获收益 (不含非经常性项目) -39.754 -348.885 -1.08951 0.40843 0.0661
普通股股东可获收益 (含非經常性項目) -39.754 -348.885 -1.08951 0.40843 0.0661
摊薄净收入 -39.754 -348.885 -1.08951 0.40843 0.0661
摊薄后加权平均股 65.7668 46.9177 2.73626 5.08836 8.92497
扣除特别项目的每股摊薄盈利 -0.60447 -7.43611 -0.39818 0.08027 0.00741
Dividends per Share - Common Stock Primary Issue
每股正常摊薄盈利 -0.60447 -6.98329 -0.48181 0.08027 0.00741
异常费用(收入) 0 21.245 -0.35207
研究与开发 17.027 20.257
Other Operating Expenses, Total 0 -0.771
其他,净值 4.077 20.938
Total Adjustments to Net Income 0 -255.822
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 0 0 0 0 0
总营业费用 9.435 9.888 9.141 9.6 15.705
销售/一般/行政费用,总计 5.785 5.432 5.012 6.642 10.222
研究与开发 3.65 4.456 4.129 2.958 5.483
异常费用(收入) 0 0 0 0
Other Operating Expenses, Total 0 0 0 0
营业收入 -9.435 -9.888 -9.141 -9.6 -15.705
利息收入(费用),非经营净值 0.168 0.152 0.058 0.139 0.154
其他,净值 -1.772 -0.505 0 2.479 2.103
税前净收入 -11.039 -10.241 -9.083 -6.982 -13.448
税后净收入 -11.039 -10.241 -9.083 -6.982 -13.448
未计算非常项目前的净收益 -11.039 -10.241 -9.083 -6.982 -13.448
净收入 -11.039 -10.241 -9.083 -6.982 -13.448
Total Adjustments to Net Income 0
普通股股东可获收益 (不含非经常性项目) -11.039 -10.241 -9.083 -6.982 -13.448
普通股股东可获收益 (含非經常性項目) -11.039 -10.241 -9.083 -6.982 -13.448
摊薄净收入 -11.039 -10.241 -9.083 -6.982 -13.448
摊薄后加权平均股 67.4539 66.4699 66.4496 65.7323 63.6675
扣除特别项目的每股摊薄盈利 -0.16365 -0.15407 -0.13669 -0.10622 -0.21122
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.16365 -0.15407 -0.13669 -0.10622 -0.21122
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 25.795 32.714 0.08246 0.06949 0.03019
现金和短期投资 20.054 27.605 0.00047 0.00001 0.01108
Cash 20.054 27.605 0.00047 0.00001 0.01108
Prepaid Expenses 5.734 5.109 0.08199 0.06948 0.01911
Total Assets 25.816 32.729 6.05041 32.0747 70.7962
Long Term Investments 5.96795 32.0052 70.766
Total Current Liabilities 15.585 11.923 0.60951 0.62244 0.56741
Payable/Accrued 0.60951 0.62244 0.5511
Accrued Expenses 4.513 1.632 0
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 18.407 11.923 3.93664 2.57421 1.25741
Total Long Term Debt 2.822 0 2.67204 1.95176 0.69
Total Equity 7.409 20.806 2.11376 29.5005 69.5387
Common Stock 0.067 0.059 0.00269 24.5033 64.5415
Additional Paid-In Capital 230.339 203.99 2.83109 4.62766 5.03621
Retained Earnings (Accumulated Deficit) -222.997 -183.243 -0.72002 0.3695 -0.03893
Total Liabilities & Shareholders’ Equity 25.816 32.729 6.05041 32.0747 70.7962
Total Common Shares Outstanding 66.443 58.8106 2.68824 5.14975 9.0355
Other Current Liabilities, Total 1.293 6.086 0 0.01631
Long Term Debt 2.822 2.67204 1.95176 0.69
Preferred Stock - Non Redeemable, Net 0 0 0
Other Liabilities, Total 0.6551
Other Current Assets, Total 0.007 0
Other Long Term Assets, Total 0.021 0.015
Accounts Payable 2.076 3.687
Current Port. of LT Debt/Capital Leases 7.703 0.518
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 21.756 25.795 24.801 32.414 43.584
现金和短期投资 16.506 20.054 18.249 24.548 40.202
Cash 16.506 20.054 18.249 24.548 40.202
Prepaid Expenses 5.244 5.734 6.005 7.312 3.382
Total Assets 21.78 25.816 24.824 32.433 43.601
Long Term Investments
Total Current Liabilities 22.064 15.585 8.042 7.081 11.912
Payable/Accrued
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 22.064 18.407 8.042 7.081 11.912
Total Long Term Debt 0 2.822 0 0 0
Long Term Debt 0 2.822
Other Liabilities, Total
Total Equity -0.284 7.409 16.782 25.352 31.689
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.07 0.067 0.068 0.067 0.067
Additional Paid-In Capital 233.576 230.339 229.47 228.958 228.313
Retained Earnings (Accumulated Deficit) -234.036 -222.997 -212.756 -203.673 -196.691
Total Liabilities & Shareholders’ Equity 21.78 25.816 24.824 32.433 43.601
Total Common Shares Outstanding 70.3097 66.443 67.6413 66.6413 66.6413
应收账款总额,净额
Accounts Receivable - Trade, Net
Other Current Assets, Total 0.006 0.007 0.547 0.554
Other Long Term Assets, Total 0.024 0.021 0.023 0.019 0.017
Accounts Payable 3.776 2.076 2.168 3.078 4.311
Accrued Expenses 4.797 4.513 4.803 3.146 2.947
Current Port. of LT Debt/Capital Leases 12.189 7.703 0 0 0.52
Other Current Liabilities, Total 1.302 1.293 1.071 0.857 4.134
Other Equity, Total 0.106
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -39.754 -93.063 -1.08951 0.40843 0.0661
经营活动产生的现金 -39.755 -37.703 -0.59862 -0.79273 -0.47319
非现金物品 -0.704 60.256 0.30303 0
营运资金的变化 0.699 -4.898 0.18787 -1.20116 -0.53929
投资活动产生的现金 -0.01 -0.007 26.176 40.2466 -0.64761
其他投资现金流量项目,总计 26.176 40.2466 -0.64761
融资活动产生的现金 32.214 63.456 -25.577 -39.4649 0.6825
融资现金流项目 0 11.05 0 -0.0075
股票的发行(报废),净额 22.712 53.682 -26.2972 -40.7267 0
债务的发行(退还),净额 9.502 -1.276 0.72027 1.26176 0.69
现金净变化 -7.551 25.746 0.00046 -0.01107 -0.4383
Cash Taxes Paid 0 0.17
经营活动产生的现金 0.004 0.002
资本支出 -0.01 -0.007
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -11.039 -39.754 -29.513 -20.43 -13.448
Cash From Operating Activities -6.089 -39.755 -31.437 -25.171 -10.38
Cash From Operating Activities 0.001 0.004 0.003 0.002 0.001
Non-Cash Items 2.455 -0.704 -1.956 -2.534 -0.924
Changes in Working Capital 2.494 0.699 0.029 -2.209 3.991
Cash From Investing Activities -0.004 -0.01 -0.011 -0.006 -0.003
Capital Expenditures -0.004 -0.01 -0.011 -0.006 -0.003
Cash From Financing Activities 2.545 32.214 22.092 22.12 22.98
Issuance (Retirement) of Stock, Net 2.545 22.712 22.61 22.638 22.98
Net Change in Cash -3.548 -7.551 -9.356 -3.057 12.597
Financing Cash Flow Items 0 0 0
Issuance (Retirement) of Debt, Net 9.502 -0.518 -0.518
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Javitt (Jonathan C) Individual Investor 20.578 14468329 0 2023-04-27 LOW
Javitt (Daniel C) Individual Investor 13.7154 9643234 0 2023-04-27 LOW
Hurvitz (Chaim) Individual Investor 3.2818 2307453 162660 2023-04-27 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1023 1478153 34990 2023-03-31 LOW
Willard (Stephen H) Individual Investor 1.4934 1050000 0 2023-04-27 LOW
Flynn (Patrick John) Individual Investor 1.071 752996 162660 2023-04-27 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5386 378667 0 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.5242 368598 2718 2023-03-31 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.3281 230700 52000 2023-03-31
Gorovitz (Aaron) Individual Investor 0.2906 204346 162660 2023-04-27 MED
Glied (Sharon A) Individual Investor 0.2501 175828 162660 2023-04-27 MED
Besthof (Robert) Individual Investor 0.233 163827 140117 2023-04-27 MED
Orfeo Capital SGIIC SA Investment Advisor 0.1841 129449 117224 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1625 114240 0 2023-03-31 LOW
Susquehanna International Group, LLP Investment Advisor 0.1147 80623 52895 2023-03-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1013 71241 12643 2023-03-31 LOW
Texas Capital Bank Private Wealth Advisors Investment Advisor 0.09 63290 0 2023-03-31 LOW
HBKS Wealth Advisors Investment Advisor 0.0831 58460 58460 2022-12-31 MED
Van Voorhees (Seth L) Individual Investor 0.0659 46337 0 2023-04-27 HIGH
Virtu Americas LLC Research Firm 0.0657 46210 46210 2023-03-31 HIGH

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

NRx Pharmaceuticals, Inc. Company profile

关于 NRx Pharmaceuticals Inc.

NRX Pharmaceuticals, Inc.的前身是Big Rock Partners Acquisition Corp.,是一家以病人为中心的临床阶段制药公司。 该公司专注于开发NRX-101。 NRX-101是一种治疗双相情感障碍的急性自杀行为/痴呆的口服治疗药物,以及治疗COVID-19呼吸衰竭的静脉注射和吸入药物ZYESAMI (aviptadil)。 NRX-101旨在提供一种口服、快速发作和持续的家庭使用疗法,可以延长氯胺酮的抗自杀益处,并减少氯胺酮的副作用。 公司将D-环丝氨酸(DCS)(一种N-甲基-D-天门冬氨酸(NMDA)受体调节剂)和鲁拉西酮(一种5-HT2a受体拮抗剂)相结合。 NRX-101正处于临床测试的第三阶段。

Industry: Biotechnology & Medical Research (NEC)

1201 Orange Street
Suite 600
WILMINGTON
DELAWARE 19801
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,946.19 Price
-0.850% 1D Chg, %
多头隔夜费 -0.0090%
空头隔夜费 0.0008%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

14,304.60 Price
-1.820% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 1.8

XRP/USD

0.52 Price
-0.220% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00396

Oil - Crude

72.36 Price
+1.300% 1D Chg, %
多头隔夜费 -0.0156%
空头隔夜费 -0.0063%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易